Trends in breast cancer incidence and mortality in the United States: implications for prevention (Q38094973)

28 August 2017

title

Trends in breast cancer incidence and mortality in the United States: implications for prevention (English)

1 reference

28 August 2017

1 reference

United States of America

1 reference

Adetunji T Toriola

1

0 references

Graham Colditz

object named as

Graham A Colditz

series ordinal

2

0 references

language of work or name

English

0 references

publication date

2 April 2013

1 reference

Breast Cancer Research and Treatment

28 August 2017

published in

1 reference

28 August 2017

volume

138

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

665-673

1 reference

Breast cancer statistics, 2011.

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Reproductive factors and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Adult weight change and risk of postmenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Mammographic density, lobular involution, and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Clinical practice. Breast-cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Projected changes in breast cancer incidence due to the trend toward delayed childbearing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Fertility and abortion rates in the United States, 1960-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Risk factors for breast cancer according to estrogen and progesterone receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Nurses' health study: log-incidence mathematical model of breast cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Delayed childbearing by education level in the United States, 1969-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

National use of postmenopausal hormone therapy: annual trends and response to recent evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Oral contraceptives in relation to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Using mammography for cancer control: an unrealized potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Rising incidence of breast cancer: relationship to stage and receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Breast cancer incidence after the start of mammography screening in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

A prospective study of postmenopausal estrogen therapy and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Incidence of and treatment for ductal carcinoma in situ of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

The decrease in breast-cancer incidence in 2003 in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Hormone therapy prescribing patterns in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Breast Cancer Incidence and Hormone Replacement Therapy in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Short-term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Breast cancer incidence rates in U.S. women are no longer declining

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Breast cancer decline mirrors fall in hormone use, spurs both debate and research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Breast cancer after use of estrogen plus progestin in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Regional changes in hormone therapy use and breast cancer incidence in California from 2001 to 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Effect of screening and adjuvant therapy on mortality from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

The benefits and harms of breast cancer screening: an independent review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Breast cancer incidence and mortality trends in 16 European countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Effect of three decades of screening mammography on breast-cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Biologic characteristics of interval and screen-detected breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Risk for distant recurrence of breast cancer detected by mammography screening or other methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Rethinking screening for breast cancer and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

The cervical cancer epidemic that screening has prevented in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

The natural history of invasive breast cancers detected by screening mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

The development of endocrine therapy for women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Triple-Negative Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Incidence of breast cancer in the United States: current and future trends.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Fruit and vegetable intake and risk of breast cancer by hormone receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Physical activity and risk of breast cancer: a meta-analysis of prospective studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

A decade of postmenopausal hormone therapy prescribing in the United States: long-term effects of the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

The epidemiology of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

The decline in breast cancer mortality in Europe: An update (to 2009)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2500-7

10.1007/S10549-013-2500-7

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1025283951

0 references

1 reference